116 related articles for article (PubMed ID: 9512876)
21. Age-dependent hyperresponsiveness of spontaneously hypertensive rats to the pressor effects of intravenous neuropeptide Y (NPY): role of mode of peptide administration and plasma NPY-like immunoreactivity.
Miller DW; Tessel RE
J Cardiovasc Pharmacol; 1991 Nov; 18(5):647-56. PubMed ID: 1723760
[TBL] [Abstract][Full Text] [Related]
22. Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.
Yang XP; Chiba S
Br J Pharmacol; 2000 Aug; 130(7):1699-705. PubMed ID: 10928977
[TBL] [Abstract][Full Text] [Related]
23. Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226.
Abounader R; Villemure JG; Hamel E
Br J Pharmacol; 1995 Oct; 116(4):2245-50. PubMed ID: 8564255
[TBL] [Abstract][Full Text] [Related]
24. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
Tovote P; Meyer M; Beck-Sickinger AG; von Hörsten S; Ove Ogren S; Spiess J; Stiedl O
Regul Pept; 2004 Aug; 120(1-3):205-14. PubMed ID: 15177939
[TBL] [Abstract][Full Text] [Related]
25. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
Kask A; Rägo L; Harro J
Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
[TBL] [Abstract][Full Text] [Related]
26. The Y1 receptor subtype mediates the cardiovascular changes evoked by NPY administered into the posterior hypothalamic nucleus of conscious rat.
Martin JR
Brain Res; 2004 Mar; 1002(1-2):11-20. PubMed ID: 14988028
[TBL] [Abstract][Full Text] [Related]
27. Role of NPY Y1 receptors in cardiovascular control in the conscious rabbit.
Serone AP; Wright CE; Angus JA
J Cardiovasc Pharmacol; 2000 Feb; 35(2):315-21. PubMed ID: 10672867
[TBL] [Abstract][Full Text] [Related]
28. Cardiac function in neuropeptide Y Y4 receptor-knockout mice.
Smith-White MA; Herzog H; Potter EK
Regul Pept; 2002 Dec; 110(1):47-54. PubMed ID: 12468109
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304.
Kask A; Harro J
Neuropharmacology; 2000 Apr; 39(7):1292-302. PubMed ID: 10760371
[TBL] [Abstract][Full Text] [Related]
30. Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle.
Hoyo Y; McGrath JC; Vila E
J Pharmacol Exp Ther; 2000 Jul; 294(1):38-44. PubMed ID: 10871293
[TBL] [Abstract][Full Text] [Related]
31. BIBP 3226 inhibition of nicotinic receptor mediated chromaffin cell secretion.
Zhang P; Zheng J; Hexum TD
Eur J Pharmacol; 1998 Dec; 362(2-3):121-5. PubMed ID: 9874161
[TBL] [Abstract][Full Text] [Related]
32. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
[TBL] [Abstract][Full Text] [Related]
33. Intracerebroventricular injection of a neuropeptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery occlusion in rats.
Chen SH; Cheung RT
Neuroscience; 2003; 116(1):119-26. PubMed ID: 12535945
[TBL] [Abstract][Full Text] [Related]
34. Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneously hypertensive rats.
Vonend O; Okonek A; Stegbauer J; Habbel S; Quack I; Rump LC
Cardiovasc Res; 2005 May; 66(2):345-52. PubMed ID: 15820203
[TBL] [Abstract][Full Text] [Related]
35. Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity.
Dimitrov EL; DeJoseph MR; Brownfield MS; Urban JH
Endocrinology; 2007 Aug; 148(8):3666-73. PubMed ID: 17463058
[TBL] [Abstract][Full Text] [Related]
36. Blockage of peripheral NPY Y1 and Y2 receptors modulates barorefex sensitivity of diabetic rats.
Liu J; Wang N; Xie F; Sun LH; Chen QX; Ye JH; Cai BZ; Yang BF; Ai J
Cell Physiol Biochem; 2013; 31(2-3):421-31. PubMed ID: 23548582
[TBL] [Abstract][Full Text] [Related]
37. Increased vasopressor actions of intraventricular neuropeptide Y-(13-36) in spontaneously hypertensive versus normotensive Wistar-Kyoto rats. Possible relationship to increases in Y2 receptor binding in the nucleus tractus solitarius.
Aguirre JA; Hedlund PB; Narváez JA; Bunnemann B; Ganten D; Fuxe K
Brain Res; 1995 Jul; 684(2):159-64. PubMed ID: 7583217
[TBL] [Abstract][Full Text] [Related]
38. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.
Bacchi F; Mathé AA; Jiménez P; Stasi L; Arban R; Gerrard P; Caberlotto L
Peptides; 2006 Dec; 27(12):3202-7. PubMed ID: 16959374
[TBL] [Abstract][Full Text] [Related]
39. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
Modin A; Malmström RE; Meister B
Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
[TBL] [Abstract][Full Text] [Related]
40. Neuropeptide Y-Y1 receptor agonist worsens while antagonist improves survival of cultured Y1-expressing neuronal cells following oxygen and glucose deprivation.
Chen SH; Cheung RT
J Biomed Sci; 2004; 11(6):781-8. PubMed ID: 15591775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
